ライフサイエンスコーパス: trypsin inhibitor

1 fragment size and both CD44 and inter-alpha-trypsin inhibitor.

2 hibitors (FUT-175 or MPI-0442352) or soybean trypsin inhibitor.

3 chymotrypsin despite the presence of Kunitz trypsin inhibitor.

4 ted in mice with higher pancreatic levels of trypsin inhibitor.

5 ed with the heavy chains (HC) of inter-alpha-trypsin inhibitor.

6 etween tick anticoagulant peptide and bovine trypsin inhibitor.

7 plasmin and was readily inhibited by soybean trypsin inhibitor.

8 athway coagulation was suppressed using corn trypsin inhibitor.

9 that of native BPTI, and to be a functional trypsin inhibitor.

10 -4 is 8.6 times higher than purified soybean trypsin inhibitor.

11 gth of interactions of the bovine pancreatic trypsin inhibitor.

12 us reactivation of reduced bovine pancreatic trypsin inhibitor.

13 pidermis of newborn rats, as well as soybean trypsin inhibitor.

14 nus of chemically modified bovine pancreatic trypsin inhibitor.

15 either cell-surface HA or serum inter-alpha-trypsin inhibitor.

16 Yet, the Y35G variant is a potent trypsin inhibitor.

17 viations were observed for bovine pancreatic trypsin inhibitor.

18 protein, alpha-tocopherol and Soybean Kunitz Trypsin Inhibitor.

19 cotyledon proteins, seed lectin, and Kunitz trypsin inhibitor.

20 less flexible crambin and bovine pancreatic trypsin inhibitor.

21 d inhibited by C1 inhibitor (C1-INH) or corn trypsin inhibitor.

22 ked to the heavy chain (HC) 1 of inter-alpha-trypsin inhibitor.

23 ation sites in the protein bovine pancreatic trypsin inhibitor.

24 d a significant reduction in the activity of trypsin inhibitors.

25 itate the digestion of foods rich in natural trypsin inhibitors.

26 uman mesotrypsin is digestive degradation of trypsin inhibitors.

27 soflavone forms and the residual activity of trypsin inhibitors.

28 rsion of isoflavones and the inactivation of trypsin inhibitors.

29 signal occurred upon administration of known trypsin inhibitors.

30 h as LTPs, omega5-gliadins and alpha-amylase/trypsin inhibitors.

31 esis of a functional analog of the Sunflower Trypsin Inhibitor 1.

32 ata B1, alpha-conotoxin Vc1.1, and sunflower trypsin inhibitor 1.

33 stances tested were tannins (20.7 mg g(-1)), trypsin inhibitor (1.45TIU mg g(-1)), nitrate (17 mg g(-

34 Sunflower trypsin inhibitor-1 (1, SFTI-1), isolated from sunflower

35 Sunflower trypsin inhibitor-1 (SFTI-1) and Momordica cochinchinens

36 thepsin G substrate sequences into sunflower trypsin inhibitor-1 (SFTI-1) produced a potent cathepsin

37 The plant-derived cyclic peptide, sunflower trypsin inhibitor-1 (SFTI-1), is a promising drug scaffo

38 d the recently discovered circular sunflower trypsin inhibitor-1 (SFTI-1).

39 s) into the cyclic peptide SFTI-1 (sunflower trypsin inhibitor-1) and a heterodimeric 2S albumin.

40 s annuus PawS1 (preproalbumin with sunflower trypsin inhibitor-1) and provide new insights into the p

41 thetic inhibitor library (based on sunflower trypsin inhibitor-1) for characterizing the P2' specific

42 untreated samples contained a high level of trypsin inhibitor (2474.3-3271.4 trypsin inhibitor units

43 he antinutritional content of lectins (48%), trypsin inhibitor (57%), amylase inhibitor (49%) and phy

44 K) (85.4%), benzamidine (80.2%), and soybean trypsin inhibitor (75.6%) and partially inhibited by N-t

45 blished using radiolabeled bovine pancreatic trypsin inhibitor (a non-hNE-binding peptide of similar

46 thway of coagulation was inhibited with corn trypsin inhibitor (a specific factor XIIa inhibitor with

47 was added to blood anticoagulated with corn trypsin inhibitor (a specific inhibitor of Factor XIIa w

48 disulfide proteins, namely bovine pancreatic trypsin inhibitor, a protein with three disulfides, and

49 n bone marrow cultures treated with soy bean trypsin inhibitor, a serine protease inhibitor, but this

50 Addition of MEK-1 inhibitors, trypsin inhibitors, a scrambled PAR-2 peptide, and silen

51 Pretreating duodenase with soybean trypsin inhibitor abolished DNA synthesis, confirming th

52 mesilate (acinar cell permeable) or soybean trypsin inhibitor (acinar cell nonpermeable) was adminis

53 caused a substantial reduction in urease and trypsin inhibitor activities and considerable decrease w

54 ared to the churi fractions (32-33%) and the trypsin inhibitor activities were found to be negligible

55 No major difference in the trypsin inhibitor activity among AF, Rs and Rc was obser

56 In gel trypsin inhibitor activity assays revealed a major clear

57 ong AF, Rs and Rc was observed; however, the trypsin inhibitor activity was drastically reduced in th

58 ith isoflavone conversions and reductions in trypsin inhibitor activity.

59 fied were beta-conglycinin, glycinin, Kunitz trypsin inhibitor, alcohol dehydrogenase, Gly m Bd 28K a

60 Feeding of soybean trypsin inhibitor and Aedes aegypti trypsin modulating o

61 duce susceptibility to inhibition by soybean trypsin inhibitor and antithrombin III.

62 n-derived serine protease inhibitors soybean trypsin inhibitor and Bowman-Birk inhibitor inhibit prot

63 o globular proteins, i.e., bovine pancreatic trypsin inhibitor and equine metmyoglobin, on the confor

64 ulfide proteins, including bovine pancreatic trypsin inhibitor and hirudin.

65 IR treatment had a more pronounced effect on trypsin inhibitor and lipoxygenase activities of soaked

66 Soybean trypsin inhibitor and phenylmethylsulphonylflouride comp

67 We illustrate them using bovine pancreatic trypsin inhibitor and present a new, detailed analysis o

68 y factor in the ability of bovine pancreatic trypsin inhibitor and similar inhibitors to resist hydro

69 two isoleucine residues in bovine pancreatic trypsin inhibitor and the four isoleucines in a cytochro

70 This increase was abolished by soybean trypsin inhibitor and was susceptible to carboxypeptidas

71 umor-related protein, similar to Kunitz-type trypsin inhibitors and (c) ribosomal protein S14.

72 in that is uniquely resistant to polypeptide trypsin inhibitors and can cleave some inhibitors rapidl

73 t displays unusual resistance to polypeptide trypsin inhibitors and has been observed to cleave sever

74 ogous to the reactive site bond of canonical trypsin inhibitors and suggest that this surface loop mi

75 Endogenous trypsin inhibitors and upregulation of proteins includin

76 ase regulators (e.g., complement factors and trypsin inhibitors) and intracellular proteins (e.g., he

77 Model proteins were studied: ribonuclease A, trypsin inhibitor, and carbonic anhydrase, where the lat

78 pancreatic ribonuclease A, bovine pancreatic trypsin inhibitor, and chicken egg white lysozyme), as c

79 ved structures of barstar, bovine pancreatic trypsin inhibitor, and lysozyme show that even before an

80 rbonic anhydrase, alpha-lactalbumin, soybean trypsin inhibitor, and ovalbumin was separated using CEC

81 resis and ligand blot with biotinylated corn trypsin inhibitor, and positive bands were sequenced.

82 f the polar side-chains in bovine pancreatic trypsin inhibitor, and their 666 interaction energies, t

83 soybean trypsin inhibitor, bovine pancreatic trypsin inhibitor, antithrombin III, and alpha2-macroglo

84 Endogenous trypsin inhibitors are believed to inhibit protease acti

85 Phytic acid, tannins and trypsin inhibitor as antinutrients were detected.

86 hy and affinity chromatography by using corn trypsin inhibitor as ligand.

87 ticide residues (37 compounds), cyanide, and trypsin inhibitor, as well as Pb, Cd, nitrate, and nitri

88 lipids, and inactivation of lipoxygenase and trypsin inhibitors, as compared to isopropanol containin

89 large values reported for bovine pancreatic trypsin inhibitor at more extreme conditions of 60 degre

90 Wheat amylase-trypsin inhibitors (ATIs) are nutritional activators of

91 BACKGROUND & AIMS: Wheat amylase-trypsin inhibitors (ATIs) are nutritional activators of

92 We identify the alpha-amylase/trypsin inhibitors (ATIs) CM3 and 0.19, pest resistance

93 e precursor form of the Arabidopsis thaliana trypsin inhibitor (ATT(p), GenBank entry Z46816), a 68-r

94 th proteinaceous inhibitors, such as soybean trypsin inhibitor, basic pancreatic trypsin inhibitor, o

95 tion via (1) inclusion of the small molecule trypsin inhibitor benzamidine in the growth medium; or (

96 of BZiPAR fluorescence was inhibited by the trypsin inhibitor benzamidine.

97 Corn trypsin inhibitor binds to prekallikrein to prevent rPRC

98 Active monomers are inhibited by soybean trypsin inhibitor, bovine pancreatic trypsin inhibitor,

99 between a cleaved form of bovine pancreatic trypsin inhibitor (BPTI) and a catalytically inactive tr

100 shed crystal structures of bovine pancreatic trypsin inhibitor (BPTI) and alpha-DtX.

101 esistance to inhibition by bovine pancreatic trypsin inhibitor (BPTI) and amyloid precursor protein K

102 eme models, represented by bovine pancreatic trypsin inhibitor (BPTI) and hirudin.

103 erent protein cavities, in bovine pancreatic trypsin inhibitor (BPTI) and in the I76A mutant of barna

104 onformational ensembles of bovine pancreatic trypsin inhibitor (BPTI) are accessed by replacing Cys 5

105 d-millisecond time scale in basic pancreatic trypsin inhibitor (BPTI) are investigated using nuclear

106 The 'core elements' in bovine pancreatic trypsin inhibitor (BPTI) are the two long strands of ant

107 uine metmyoglobin (Mb) and bovine pancreatic trypsin inhibitor (BPTI) at concentrations up to 0.4 and

108 ics simulations of reduced bovine pancreatic trypsin inhibitor (BPTI) at high temperature in water an

109 ture of the thrombin E192Q-bovine pancreatic trypsin inhibitor (BPTI) complex, the structural basis f

110 n, G37A, on the surface of bovine pancreatic trypsin inhibitor (BPTI) destabilizes the protein by app

111 Bovine pancreatic trypsin inhibitor (BPTI) forms an extremely stable and c

112 Bovine pancreatic trypsin inhibitor (BPTI) has been widely used as a model

113 Tyr35-->Gly replacement in bovine pancreatic trypsin inhibitor (BPTI) has previously been shown to dr

114 The oxidative folding of bovine pancreatic trypsin inhibitor (BPTI) has served as a paradigm for th

115 d by expressing mutants of bovine pancreatic trypsin inhibitor (BPTI) in yeast.

116 sulfide folding pathway of bovine pancreatic trypsin inhibitor (BPTI) is characterized by the predomi

117 ly link a terminal 6.5-kDa bovine pancreatic trypsin inhibitor (BPTI) moiety to prOE17 to create the

118 with a potent (Ki=0.4 nM) bovine pancreatic trypsin inhibitor (BPTI) mutant (5L15), a homolog of TFP

119 hibitors homologous to the bovine pancreatic trypsin inhibitor (BPTI) provide a suitable scaffold, bu

120 the Kunitz-type inhibitor bovine pancreatic trypsin inhibitor (BPTI) to probe fIXa reactivity in the

121 ng kinetics of a series of bovine pancreatic trypsin inhibitor (BPTI) variants with similar stabiliti

122 n the backbone dynamics of bovine pancreatic trypsin inhibitor (BPTI) were examined using 15N NMR rel

123 tially folded analogues of bovine pancreatic trypsin inhibitor (BPTI) with the proteolytically inacti

124 ingle-disulfide variant of bovine pancreatic trypsin inhibitor (BPTI), [14-38]Abu, is a partially fol

125 We have found that bovine pancreatic trypsin inhibitor (BPTI), a Kunitz protease inhibitor, i

126 acellular binding site for bovine pancreatic trypsin inhibitor (BPTI), a well-known inhibitor of vari

127 -disulfide intermediate of bovine pancreatic trypsin inhibitor (BPTI), with the disulfide between Cys

128 lidated using ubiquitin and basic pancreatic trypsin inhibitor (BPTI).

129 including heparin and the bovine pancreatic trypsin inhibitor (BPTI).

130 disulfide intermediates of bovine pancreatic trypsin inhibitor (BPTI).

131 > L and F --> L mutants of bovine pancreatic trypsin inhibitor (BPTI).

132 s of two modified forms of bovine pancreatic trypsin inhibitor (BPTI).

133 at positions 30 and 51 in bovine pancreatic trypsin inhibitor (BPTI).

134 a small globular protein, bovine pancreatic trypsin inhibitor (BPTI).

135 ng experiment conducted on bovine pancreatic trypsin inhibitor (BPTI; 58 residues) suggested that if

136 tion of diffusion coefficients for lysozyme, trypsin inhibitor, BSA, and IgG both inside the hydrogel

137 nt rat corin was inhibited by small molecule trypsin inhibitors but not inhibitors for matrix metallo

138 e similar to the ADP-ribosylation of soybean trypsin inhibitor by ExoS.

139 ces covalent modification of the inter-alpha-trypsin inhibitor by TSG-6 and transfer of its heavy cha

140 endogenous CCK by administering a synthetic trypsin inhibitor, camostat (100 mg/kg).

141 PSTI-I to the pancreas increased endogenous trypsin inhibitor capacity by 190% (P <.01) in transgeni

142 three different proteins, bovine pancreatic trypsin inhibitor, chymotrypsin inhibitor 2, and barnase

143 fective at blocking the chymotrypsin-soybean trypsin inhibitor complex and that the mechanism involve

144 we demonstrate that benzamidine and soybean trypsin inhibitor-conjugated Sepharose beads, which bind

145 The trypsin inhibitors content was almost abolished by canni

146 site of ribonuclease and the K15 site of the trypsin inhibitor could be readily acylated by the enzym

147 or plasma (PPP), either with or without corn trypsin inhibitor (CTI) to prevent contact activation, o

148 ate, ethylenediaminetetraacetatic acid, corn trypsin inhibitor (CTI, an inhibitor of activated factor

149 reagent and contact pathway inhibitor (corn trypsin inhibitor, CTI) to develop a reproducible thromb

150 annexin A1 protein grafted into a sunflower trypsin inhibitor cyclic scaffold.

151 rformed for five proteins: bovine pancreatic trypsin inhibitor, cytochrome c, plastocyanin, staphyloc

152 SPINK1, a secretory trypsin inhibitor, demonstrated potential as a diagnosti

153 however, partially reduced bovine pancreatic trypsin inhibitor (des(14-38)) is not.

154 d SPINK1 or other nonpermeable proteinaceous trypsin inhibitors did not restore normal secretion of t

155 ch domains, a von Willebrand D domain, and a trypsin inhibitor domain.

156 ase inhibitor, Enterolobium contortisiliquum trypsin inhibitor (EcTI), on the adhesion, migration, an

157 ely 6- to 7-kDa) peptides, bovine pancreatic trypsin inhibitor, epidermal growth factor, human neutro

158 Soybean trypsin inhibitor exhibited a reciprocal pattern, inhibi

159 onan and the heavy chains of the inter-alpha-trypsin inhibitor family.

160 hat LTI is a member of the bovine pancreatic trypsin inhibitor family.

161 ty places the encoded protein in the soybean trypsin-inhibitor family (Kunitz).

162 Bovine pancreatic trypsin inhibitor follows the same general phase behavio

163 enzymatic activity of trypsin and to screen trypsin inhibitors for their inhibition efficiency.

164 itor-II (MCoTI-II), a structurally divergent trypsin inhibitor from Momordica cochinchinensis that al

165 families: cyclotides and circular sunflower trypsin inhibitors from the kingdom of plants and the Am

166 plete removal of guanidine, which is a known trypsin inhibitor, from the digestion buffer.

167 Loss of trypsin inhibitor function may have similar effects.

168 her KLK5 activity by the inhibitor sunflower trypsin inhibitor G, restoration of DSG1 expression and

169 c trypsinogen gene, the pancreatic secretory trypsin inhibitor gene, and the cystic fibrosis transmem

170 enoxaparin is greatest for basic pancreatic trypsin inhibitor (>10-fold), followed by the second tis

171 phases carrying long alkyl chains or soybean trypsin inhibitor have been prepared for use in HPLC sep

172 ; and (c) a cleavage fragment of inter-alpha-trypsin inhibitor heavy chain H4 (up-regulated).

173 ng a positive regulator of IL-6, Inter-alpha-trypsin inhibitor-heavy chain-4 (ITIH4), resulted in red

174 high-molecular-weight derivative of soybean trypsin inhibitor (hMW-SBTI) which was unable to pass th

175 inhibitors (lkiL-1, lkiL-2, lkiL-3), potato trypsin inhibitor I (ptiIL-1), serpins (serpL-1), cystat

176 her increased levels of pancreatic secretory trypsin inhibitor-I (PSTI-I) in mice could prevent secre

177 Inter-alpha-trypsin inhibitor (IaI) is an abundant serum protease in

178 Inter-alpha-trypsin inhibitor (IaI) is an abundant serum protein.

179 ent linkage between HC1 from the inter-alpha-trypsin inhibitor (IalphaI) and HA, purified from the hu

180 g demonstrates components of the inter-alpha-trypsin inhibitor (IalphaI) complex in both coat-like an

181 Inter-alpha-trypsin inhibitor (IalphaI) is a complex comprising two

182 Additionally, the inter-alpha-trypsin inhibitor (IalphaI), a proteoglycan essential fo

183 a complex with a serine protease inter-alpha-trypsin inhibitor (IalphaI), increasing the protease inh

184 to hyaluronan and interacts with inter-alpha-trypsin inhibitor (IalphaI), molecules that are essentia

185 which the heavy chains (HCs) of inter-alpha-trypsin inhibitor (IalphaI)-related proteins are covalen

186 methyl acetate (IC(50) = 1 microm), and corn trypsin inhibitor (IC(50) = 40 nm).

187 cyclic miniprotein Momordica cochinchinensis Trypsin Inhibitor II (MCoTI-II) (34 amino acids) is a po

188 tor-1 (SFTI-1) and Momordica cochinchinensis trypsin inhibitor-II (MCoTI-II) are potent protease inhi

189 hips of SFTI-1 and Momordica cochinchinensis trypsin inhibitor-II (MCoTI-II), a structurally divergen

190 nhibitors based on Momordica cochinchinensis trypsin inhibitor-II.

191 iation of chymotrypsin and bovine pancreatic trypsin inhibitor in a solution mixture and simultaneous

192 antibodies, such as antipancreatic secretory trypsin inhibitor in Ela1-LTab mice.

193 (2-furoyl)quinoline-2-carboxaldehyde labeled trypsin inhibitor in one-dimensional separation; detecti

194 The presence of a trypsin inhibitor in the perivitelline fluid compartment

195 g monomers and decamers of bovine pancreatic trypsin inhibitor in the presence of dextran up to a mac

196 eted protein, we expressed bovine pancreatic trypsin inhibitor in yeast.

197 roven, and the role of endogenous pancreatic trypsin inhibitors in acute pancreatitis is unknown.

198 ate, nitrite, cyanide, oxalate, phytate, and trypsin inhibitor) in tubers of Jerusalem artichokes-Kae

199 Bovine pancreatic trypsin inhibitor is a single domain, 58-amino acid poly

200 activity of factor IXa with basic pancreatic trypsin inhibitor is enhanced by low molecular weight he

201 erted the specificity of antithrombin from a trypsin inhibitor (k(assoc) = 2 x 10(5) M(-1) s(-1)) to

202 d found evidence for radiation of the Kunitz trypsin inhibitor (KTI) gene family within winged bean.

203 ructures of P1 (Lys+)15 of bovine pancreatic trypsin inhibitor (Kunitz) ( and ) and of the P1 (Lys+)1

204 vomucoid third domain, and bovine pancreatic trypsin inhibitor (Kunitz) are all standard mechanism, c

205 t in sharp contrast to the bovine pancreatic trypsin inhibitor (Kunitz) data.

206 ting the presence of three bovine pancreatic trypsin inhibitor/Kunitz domains and its high homology w

207 tail containing AEBSF, aprotinin, pancreatic trypsin inhibitor, leupeptin, antipain, and EDTA could n

208 between Cys14 and Cys38 of bovine pancreatic trypsin inhibitor lies on the surface of the inhibitor a

209 cysteine-rich motif with similarities to the trypsin inhibitor-like (TIL) domains of small serine pro

210 ein is composed of a signal sequence and two trypsin inhibitor-like domains and likely functions as a

211 erpins, Kazal-type inhibitors, cystatins and trypsin inhibitor-like molecules.

212 ontains 13 zinc-finger domains and has three trypsin inhibitor-like, cysteine-rich domains and is wid

213 mblies include von Willebrand D, 8-cysteine, trypsin inhibitor-like, E or fibronectin type 1-like dom

214 D' consists of 2 domains, trypsin-inhibitor-like (TIL') and E', of which the TIL'

215 Effects of IR treatment on urease, trypsin inhibitor, lipoxygenase-1 and lipoxygenase-3 act

216 oduce significant amounts of a novel Lymnaea trypsin inhibitor (LTI), a second peptide that was purif

217 proteins (ovalbumin, ribonuclease A, soybean trypsin inhibitor, lysozyme, and beta-lactoglobulin A an

218 l tissues where its resistance to endogenous trypsin inhibitors may permit prolonged signaling.

219 ar dynamics simulations on the cysteine-rich trypsin inhibitor MCoTI-II with three disulfide bridges.

220 ajor receptor for hyaluronan) or inter-alpha-trypsin inhibitor (molecule that facilitates hyaluronan

221 the finding and characterization of a novel trypsin inhibitor, named panulirin, isolated from the he

222 The P1 residue Arg-15 (bovine pancreatic trypsin inhibitor numbering) in KD1 interacts with Asp-1

223 containing up to 0.12 g/mL bovine pancreatic trypsin inhibitor or 0.2 g/mL metmyoglobin.

224 e degrading protease is inhibited by soybean trypsin inhibitor or by low concentrations of blood plas

225 d aprotinin, but not by soybean or lima bean trypsin inhibitors or inhibitors of other classes of pro

226 , elastin, beta-casein, plasminogen, soybean trypsin inhibitor, or Bowman-Birk inhibitor.

227 acid fragment derived from bovine pancreatic trypsin inhibitor, or misfolded proteins, the b' domain

228 soybean trypsin inhibitor, basic pancreatic trypsin inhibitor, ovomucoid turkey inhibitor, and Bowma

229 Cell death was blocked by the trypsin inhibitor Pefabloc but not by the pancaspase inh

230 Bovine pancreatic trypsin inhibitor preferred HL-BEK (initial Ki = 99 nM a

231 o-Prolinal or plasma kallikrein with soybean trypsin inhibitor, Pro-Phe-Arg-chloromethylketone or PKS

232 in the cleavage of Kunitz-bovine pancreatic trypsin inhibitor protease inhibitors by mesotrypsin, fi

233 trypsinogens I and II, pancreatic secretory trypsin inhibitor (PSTI) and plasminogen binding protein

234 on mutations of CFTR and of genes encoding a trypsin inhibitor (PSTI) and trypsinogen (PRSS1).

235 Pancreatic secretory trypsin inhibitor (PSTI) is a serine protease inhibitor,

236 e) ECaSt/PDI augmented the bovine pancreatic trypsin inhibitor reactivation rate.

237 Soybean trypsin inhibitor reduced secretion to background levels

238 Maximum trypsin inhibitor reduction in IR-treated samples was 95

239 t effective in inactivating lipoxygenase and trypsin inhibitors, retarding lipid oxidation as well as

240 n the crystal structure of bovine pancreatic trypsin inhibitor revealed that KD1 formed a more energe

241 ation of the small protein bovine pancreatic trypsin inhibitor reveals that its main conformations ha

242 gen, pepsinogen, lysozyme, bovine pancreatic trypsin inhibitor, ribonuclease A, and T4 lysozyme) were

243 ld, similar to those found in Kunitz soybean trypsin inhibitors, ricin-like toxins, plant agglutinins

244 eactive-site peptide bond of the Kunitz-type trypsin inhibitor SBTI, and irreversibly degraded the Ka

245 yme S)-dependent ADP-ribosylation of soybean trypsin inhibitor (SBTI) at 0.4% and of the Ras protein

246 o natural trypsin inhibitors such as soybean trypsin inhibitor (SBTI) or human pancreatic secretory t

247 Additionally, we found that when soybean trypsin inhibitor (SBTI), was added to rat heart effluen

248 ) in the presence and the absence of soybean trypsin inhibitor (SBTI; 100 units/g pretreated skin) fo

249 he dramatic enhancement of bovine pancreatic trypsin inhibitor self-association can be quantitatively

250 Gabexate mesilate as well as soybean trypsin inhibitor significantly decreased TAP levels in

251 se changes are mirrored in bovine pancreatic trypsin inhibitor solubility where the typical salting o

252 n the gene encoding the pancreatic secretory trypsin inhibitor SPINK1 further increase the risk of pa

253 or (2) cotransfection with the physiological trypsin inhibitor SPINK1; or (3) by mutation of the cata

254 hibitor (SBTI) or human pancreatic secretory trypsin inhibitor (SPINK1).

255 We also analyzed the soybean trypsin inhibitor (STI) gene family, important plant def

256 s affects the secondary structure of soybean trypsin inhibitor (STI).

257 The high-pH trypsin-inhibitor structures suggest that His57 is proto

258 nized for its peculiar resistance to natural trypsin inhibitors such as soybean trypsin inhibitor (SB

259 studies of factor IXa with basic pancreatic trypsin inhibitor suggest that binding of this inhibitor

260 se A, microbial ribonuclease, and pancreatic trypsin inhibitor, suggesting that an ongoing surveillan

261 not motif-containing cyclotides: Mobius (M), trypsin inhibitor (T), and bracelet (B).

262 laminin receptor (67LR) and tumor-associated trypsin inhibitor (TATI), had previously been associated

263 plex between factor IXa and basic pancreatic trypsin inhibitor that is facilitated by enoxaparin bind

264 itz-type inhibitor domains: basic pancreatic trypsin inhibitor, the Kunitz inhibitor domain of protea

265 by the complex of kallikrein and pancreatic trypsin inhibitor, the overall stability results from th

266 The determination of trypsin inhibitor (TI) activity is of importance to eval

267 r II (MCoTI-II) (34 amino acids) is a potent trypsin inhibitor (TI) and a favored scaffold for drug d

268 showed that purified CPB, in the presence of trypsin inhibitor (TI), can reproduce type C pathology i

269 sing a ladder of small-to-mid mass proteins (Trypsin Inhibitor (TI); Ovalbumin (OVA); Bovine Serum Al

270 n of CCK or intragastric administration of a trypsin inhibitor to elicit endogenous CCK release was f

271 Whole blood supplemented with corn trypsin inhibitor (to inhibit factor XIIa) was perfused

272 let-rich plasma (PRP) supplemented with corn trypsin inhibitor (to shut down contact activation) was

273 d could be applied to preclinically optimize trypsin inhibitors towards intrapancreatic target inhibi

274 Human blood (corn trypsin inhibitor treated [4 mug/mL]) was tested by micr

275 in endothelial cells in the presence of corn trypsin inhibitor treated human plasma devoid of platele

276 Corn trypsin inhibitor-treated blood was fractionated to yiel

277 Cathepsin G addition to corn trypsin inhibitor-treated PFP produced little thrombin u

278 r rate of 100-500 s(-1)) of recalcified corn trypsin inhibitor-treated whole blood or platelet rich p

279 rfusion (wall shear rate, 200 s(-1)) of corn trypsin inhibitor-treated whole blood over a 250-mum lon

280 otease inhibitor lymphoepithelial Kazal-type trypsin inhibitor type 1; and the fatty acid transporter

281 gh level of trypsin inhibitor (2474.3-3271.4 trypsin inhibitor units per gramme (TIU/g) of flour) and

282 means of hydrogen bonds in Cucurbita maxima trypsin inhibitor-V (CMTI-V), a potato I family member.

283 ding random mutations in a bovine pancreatic trypsin inhibitor variant containing a small generic tag

284 C higher than the original bovine pancreatic trypsin inhibitor variant.

285 Soybean trypsin inhibitor was added to serum before injections t

286 Soybean trypsin inhibitor was functionalized with N-(4-pentynoyl

287 mice, although the CCK secretory response to trypsin inhibitor was retained.

288 the allergen Tri a 30 (the CM3 alpha-amylase/trypsin inhibitor) was quantified in durum wheat salt so

289 rresponding to soybean agglutinin and Kunitz trypsin inhibitor were identified based on the statistic

290 the plasmin inhibitor and bovine pancreatic trypsin inhibitor were reduced by conjugation, presumabl

291 alpha-Amylase/trypsin inhibitors were also found to be involved in whe

292 The human RSL served as a trypsin inhibitor when supported by mouse scaffold seque

293 Soy bean trypsin inhibitor, when added to mast cell releasates, p

294 oncentrations of verbascoside, lignin and/or trypsin inhibitors, which decreased larval survival and/

295 We have adapted the corn-trypsin inhibitor whole-blood model to include EA.hy926

296 Bovine pancreatic trypsin inhibitor with (Lys+)15 at P1 binds to chymotryp

297 iochemical assays, reveals that it encodes a trypsin inhibitor with sequence and structural similarit

298 Moreover, pLR is a highly potent trypsin inhibitor, with Ki values in the nanomolar range

299 ally engineered variant of bovine pancreatic trypsin inhibitor (Y35G BPTI) has been shown previously

300 ne), and compare them with the corresponding trypsin-inhibitor-Zn2+ complexes.